COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 672: Articles 6711-6720  | Next

Differences in COVID-19 cyclicity and predictability among U.S. counties and states reflect the effectiveness of protective measures
Bozzuto, C., Ives, A. R.
10.1101/2022.09.28.22280465 — Posted: 2022-09-29
Populational analysis of the immunoglobulin G response to different COVID-19 vaccines in Brazil
Paula, N. M., Conzentino, M. d. S., Goncalves, A. C., Silva, R., Weissheimer, K. V., Kluge, C. H., Marins, P. H., Camargo, H. S., Farias, L. R., Santana, T. P., Vargas, L. R., Aldrighi, J. D., Lima, E. S., Jacotenski, G. T., Goncalves, A. G., Joucoski, E., Huergo, L.
10.1101/2022.09.28.22280449 — Posted: 2022-09-29
Effect of COVID-19 on Food Choices and Eating Behaviour: a study protocol
McCormack, J. C., Doughty, E., Ebron, S., Peng, M.
10.1101/2022.09.28.22280475 — Posted: 2022-09-29
COVIDpro: Database for mining protein dysregulation in patients with COVID-19
Zhang, F., Luna, A., Tan, T., Chen, Y., Sander, C., Guo, T.
10.1101/2022.09.27.509819 — Posted: 2022-09-28
Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in Syrian hamsters
Abdelnabi, R., Jochmans, D., Donckers, K., Trueeb, B., Ebert, N., Weynand, B., Thiel, V., Neyts, J.
10.1101/2022.09.28.509903 — Posted: 2022-09-28
IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding
Bolton, M., Arevalo, C. P., Griesman, T., Li, S. H., Bates, P., Wilson, P. C., Hensley, S. E.
10.1101/2022.09.27.509738 — Posted: 2022-09-28
Activation of SARS-CoV-2 by trypsin-like proteases in the clinical specimens of patients with COVID-19
Igarashi, E., Shimada, T., Yazawa, S., Saga, Y., Itamochi, M., Inasaki, N., Morinaga, Y., Oishi, K., Tani, H.
10.1101/2022.09.27.509803 — Posted: 2022-09-28
Mutational spectra distinguish SARS-CoV-2 replication niches
Ruis, C., Peacock, T. P., Polo, L. M., Masone, D., Soledad Alvarez, M., Hinrichs, A. S., Turakhia, Y., Ye, C., McBroome, J., Corbett-Detig, R., Parkhill, J., Floto, R. A.
10.1101/2022.09.27.509649 — Posted: 2022-09-28
SARS-CoV-2 variants show temperature-dependent enhancedpolymerase activity in the upper respiratory tract and high transmissibility
Kim, S.-M., Kim, E.-H., Casel, M. A. B., Kim, Y.-i., Sun, R., Kwack, M.-J., Yoo, J.-S., Yoo, M.-A., Yoo, K.-M., Jang, S.-G., Rollon, R., Choi, J. H., Gil, J., Eun, K., Kim, H., Ensser, A., Hwang, J., Song, M.-S., Kim, M. H., Jung, J. U., Choi, Y. K.
10.1101/2022.09.27.509689 — Posted: 2022-09-27
Nuclear translocation of spike mRNA and protein is a novel pathogenic feature of SARS-CoV-2.
Sattar, S., Kabat, J., Jerome, K., Feldmann, F., Bailey, K., Mehedi, M.
10.1101/2022.09.27.509633 — Posted: 2022-09-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).